Cyberonics, Inc. News

Cyberonics to Present at Jefferies 2nd Annual Healthcare Conference

HOUSTON, June 18 PRNewswire-FirstCall — Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the Jefferies 2nd Annual Healthcare Conference in New York City on Wednesday, June 25, 2008 at 11:15 AM EDT. Presentation slides will be available on-line at http://www.cyberonics.com by 8:00 AM EDT on Wednesday, June 25, 2008. Jefferies will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/jeff26/cybx. The replay will be available for 90 days following the conference. The presentation can also be accessed at http://www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

ABOUT VNS THERAPY AND CYBERONICS

Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at http://www.cyberonics.com and http://www.vnstherapy.com.

CONTACT INFORMATION: Greg Browne, CFO Cyberonics, Inc. 100 Cyberonics Blvd. Houston, TX 77058 Main: (281) 228-7262 Fax: (281) 218-9332 ir@cyberonics.com

SOURCE Cyberonics, Inc.

Send this news item to a friend.

Print This Page